Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab escalation in IBD
NCT03059849Phase 4Withdrawn
- Sponsor
- McMaster University
- Start
- Feb 2018
- Primary completion
- Feb 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, ulcerative colitis (UC), sponsored by McMaster University. Planned start Feb 2018; status: withdrawn.
02
Drugs
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03059849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059849.